Cytokine units of immunoregulation of diabetic-associated osteoarthritis

by V.L. Orlenko
Published 2020-05-01

Clinical and biochemical markers of joint damage in patients with diabetes mellitus

by V. L. Orlenko, M. D. Tronko
Published 2020-06-01

Treatment with Glucagon-Like Peptide-1 Analogues — a Breakthrough in Diabetes Mellitus Type 2 Therapy

by V.L. Orlenko, K.P. Zak
Published 2014-05-01

Clinical features and risk factors of diabetes-associated osteoarthritis

by V.L. Orlenko, М.D. Tronko, O.T. Yelizarova
Published 2020-03-01

Experience of Using Genetically Engineered Insulin Preparations Produced by Farmak Company in Patients with Diabetes Mellitus Type 2

by V.L. Orlenko, A.S. Yefimov, K.Yu. Ivaskiva
Published 2014-08-01

Insulin and leptin levels in type 1 and type 2 diabetes patients with diabetes-associated osteoarthritis

by V.L. Orlenko, M.D. Tronko, O.T. Yelizarova
Published 2019-03-01

Hyperuricemia — an independent factor for the progression of chronic kidney disease

by M.D. Tronko, M.N. Dolzhenko, S.V. Kushnirenko, V.L. Orlenko, S.V. Potashev, O.O. Shevchuk
Published 2017-04-01

The role of the immune system in mechanism of metformin therapeutic effect in patients with type 2 diabetes

by K.P. Zak, V.L. Orlenko, V.V. Popova, S.V. Melnichenko, Ya.A. Saenko, К.M. Tronko, A.V. Kulikovskaya, К.Yu. Ivaskiva
Published 2017-08-01

The role of metabolic surgery in the treatment of patients with type 2 diabetes mellitus

by M.D. Tronko, V.L. Orlenko, S.I. Savoliuk, M.Yu. Krestianov, O.V. Dobrovynska, A.Yu. Glagoleva, K.Yu. Ivaskiva, V.M. Lysenko, D.S. Zavertylenko
Published 2019-04-01